175 related articles for article (PubMed ID: 2732943)
1. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
Bean AJ; Adrian TE; Modlin IM; Roth RH
J Pharmacol Exp Ther; 1989 Jun; 249(3):681-7. PubMed ID: 2732943
[TBL] [Abstract][Full Text] [Related]
2. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine depletion on striatal neurotensin: biochemical and immunohistochemical studies.
Bean AJ; During MJ; Deutch AY; Roth RH
J Neurosci; 1989 Dec; 9(12):4430-8. PubMed ID: 2593006
[TBL] [Abstract][Full Text] [Related]
4. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
[TBL] [Abstract][Full Text] [Related]
6. Long-term reciprocal changes in dopamine levels in prefrontal cortex versus nucleus accumbens in rats born by Caesarean section compared to vaginal birth.
El-Khodor BF; Boksa P
Exp Neurol; 1997 May; 145(1):118-29. PubMed ID: 9184115
[TBL] [Abstract][Full Text] [Related]
7. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
[TBL] [Abstract][Full Text] [Related]
8. Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain.
Pilotte NS; Mitchell WM; Sharpe LG; De Souza EB; Dax EM
Synapse; 1991 Oct; 9(2):111-20. PubMed ID: 1821482
[TBL] [Abstract][Full Text] [Related]
9. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens.
Kalivas PW; Richardson-Carlson R; Duffy P
J Pharmacol Exp Ther; 1986 Sep; 238(3):1126-31. PubMed ID: 3755755
[TBL] [Abstract][Full Text] [Related]
10. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
[TBL] [Abstract][Full Text] [Related]
11. Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields.
Tyler CB; Galloway MP
J Pharmacol Exp Ther; 1992 May; 261(2):567-73. PubMed ID: 1578374
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
Compton DR; Johnson KM
J Pharmacol Exp Ther; 1989 Feb; 248(2):521-30. PubMed ID: 2918468
[TBL] [Abstract][Full Text] [Related]
14. The electrophysiological effects of neurotensin on spontaneously active neurons in the nucleus accumbens: an in vivo study.
Stowe ZN; Landry JC; Tang Z; Owens MJ; Kinkead B; Nemeroff CB
Synapse; 2005 Dec; 58(3):165-72. PubMed ID: 16108007
[TBL] [Abstract][Full Text] [Related]
15. Regulation of dopamine and serotonin synthesis by acute administration of cocaine.
Galloway MP
Synapse; 1990; 6(1):63-72. PubMed ID: 2119072
[TBL] [Abstract][Full Text] [Related]
16. Effect of a novel neurotensin analog, NT69L, on nicotine-induced alterations in monoamine levels in rat brain.
Liang Y; Boules M; Shaw AM; Williams K; Fredrickson P; Richelson E
Brain Res; 2008 Sep; 1231():6-15. PubMed ID: 18687313
[TBL] [Abstract][Full Text] [Related]
17. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Hoffmann IS; Talmaciu RK; Cubeddu LX
J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
[TBL] [Abstract][Full Text] [Related]
18. Alterations in locomotor activity after microinjections of GBR-12909, selective dopamine antagonists or neurotensin into the medial prefrontal cortex.
Radcliffe RA; Erwin VG
J Pharmacol Exp Ther; 1996 Jun; 277(3):1467-76. PubMed ID: 8667212
[TBL] [Abstract][Full Text] [Related]
19. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
Galloway MP; Wolf ME; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
[TBL] [Abstract][Full Text] [Related]
20. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
Di Matteo V; Pierucci M; Esposito E
J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
